Seastar Medical targets about $2M 2026 QUELIMMUNE revenue while aiming to finish NEUTRALIZE-AKI enrollment by end of 2026
SeaStar Medical Holding Corporation Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.64
-18% in 7d after detection
Post-detection moves
1h
—
1d
-8.7%
3d
-13%
7d
-18%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS